On the subject of a general market meltdown, Blokes, I guess such an eventuality COULD be in the wings.
But against that, we have what is widely anticipated to be a healthy reporting season for the majors just up ahead.
Besides, the biotech sector hardly looks to have moved into 'overblown' territory just yet. Indeed, given its present stage of evolution, MVH looks extremely conservatively valued at the moment.
MVH Price at posting:
0.0¢ Sentiment: Buy Disclosure: Held